Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

BACKGROUND: High costs of direct-acting antivirals (DAAs) have led health-care insurers to limit access worldwide. Using a natural experiment, we evaluated the impact of removing fibrosis stage restrictions on hepatitis C (HCV) treatment initiation rates among people living with human immunodeficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Sahar, Strumpf, Erin, Moodie, Erica E M, Wong, Leo, Cox, Joseph, Walmsley, Sharon, Tyndall, Mark, Cooper, Curtis, Conway, Brian, Hull, Mark, Martel-Laferriere, Valerie, Gill, John, Wong, Alexander, Vachon, Marie-Louise, Klein, Marina B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353326/
https://www.ncbi.nlm.nih.gov/pubmed/31504327
http://dx.doi.org/10.1093/cid/ciz833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353326/
https://www.ncbi.nlm.nih.gov/pubmed/31504327
http://dx.doi.org/10.1093/cid/ciz833

Ejemplares similares